POZ Community Forums
Meds, Mind, Body & Benefits => Research News & Studies => Topic started by: Hoyland on May 09, 2014, 02:27:54 am
-
Prof Berkhout and his team have been using similar technology to Calimmune but with different targets. This is his latest paper. As I understand it, his team still lacks the funding necessary to commence clinical trials.
http://www.futuremedicine.com/doi/abs/10.2217/fmb.14.5?journalCode=fmb (http://www.futuremedicine.com/doi/abs/10.2217/fmb.14.5?journalCode=fmb)
(A subscription is necessary to read the full article.)